Company Name: Deep Apple Therapeutics
Location: San Francisco, CA
Funding Details: Series A funding of $52M
- Investors: The round was led by Apple Tree Partners
- Purpose of Investment: Expansion of operations and advancement of development efforts
Leadership: Spiros Liras, Ph.D., Founding CEO
Product: An AI-driven discovery engine for novel small molecule therapeutics
About Company: Deep Apple Therapeutics focuses on discovering novel therapeutics for high-value targets, utilizing ensemble cryo-EM, deep learning, and molecular docking screens of ultra-large libraries. The company's approach expedites the process from target identification to lead optimization, primarily focusing on integral membrane proteins.